510(k) K053603

C-REACTIVE PROTEIN (LATEX) HIGH SENSITIVE TEST SYSTEM FOR COBAS INTEGRA INSTRUMENTS by Roche Diagnostics Corp. — Product Code NQD

K053603 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Corp. for the device "C-REACTIVE PROTEIN (LATEX) HIGH SENSITIVE TEST SYSTEM FOR COBAS INTEGRA INSTRUMENTS". The FDA issued a decision of Substantially Equivalent on Feb 9, 2006. The device falls under product code NQD (Cardiac C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Roche Diagnostics Corp. has 456 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Feb 9, 2006
Date Received
Dec 23, 2005
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type
510(k)

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.

Need the full FDA record for Roche Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K053603. Report a data issue: hello@regdatalab.com.